Literature DB >> 19088455

Phosphatidylinositide dependent kinase deficiency increases anxiety and decreases GABA and serotonin abundance in the amygdala.

Teresa F Ackermann1, Heide Hörtnagl, David P Wolfer, Giovanni Colacicco, Reinhard Sohr, Florian Lang, Rainer Hellweg, Undine E Lang.   

Abstract

Pathological anxiety is paralleled by deficits in serotonergic and GABAergic neurotransmission in the amygdala. Conversely, anxiety disorders and depression may be reversed by brain-derived neurotrophic factor (BDNF). BDNF signaling involves Phosphatidylinositol 3-Kinase / 3-phosphoinositide-dependent protein kinase 1 (PI3K/PDK1). We thus hypothesized that impaired function of PDK1 might be associated with increased anxiety and concomitant neurotransmitter changes. Here we used the hypomorphic PDK1(hm) mouse to investigate anxiety behavior in different settings: PDK1(hm) mice differed from Wt littermates PDK1(WT) in several behavioral measures related to anxiety and exploration, namely in the open field, dark-light box, O-maze and startle response. Further we analyzed the brain substrate underlying this phenotype and found significantly decreased GABA, taurine and serotonin concentrations in the amygdala and olfactory bulb of PDK1(hm) mice, while BDNF and nerve growth factor (NGF) concentrations were not significantly different between PDK1(hm) and PDK1(WT) mice. These results suggest that impaired PI3K signaling in the PDK1(hm) mouse reduces concentrations of GABA and serotonin in anxiety related brain regions and can serve as a molecular substrate for behavior indicative for anxious and depressive-like mood states. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19088455     DOI: 10.1159/000185557

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  11 in total

Review 1.  Significance of SGK1 in the regulation of neuronal function.

Authors:  Florian Lang; Nathalie Strutz-Seebohm; Guiscard Seebohm; Undine E Lang
Journal:  J Physiol       Date:  2010-06-07       Impact factor: 5.182

2.  Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

Authors:  Jordi Rodon; Irene Braña; Lillian L Siu; Maja J De Jonge; Natasha Homji; David Mills; Emmanuelle Di Tomaso; Celine Sarr; Lucia Trandafir; Cristian Massacesi; Ferry Eskens; Johanna C Bendell
Journal:  Invest New Drugs       Date:  2014-03-21       Impact factor: 3.850

3.  PI3K/Akt signaling pathway in the basolateral amygdala mediates the rapid antidepressant-like effects of trefoil factor 3.

Authors:  Hai-Shui Shi; Wei-Li Zhu; Jian-Feng Liu; Yi-Xiao Luo; Ji-Jian Si; Shen-Jun Wang; Yan-Xue Xue; Zeng-Bo Ding; Jie Shi; Lin Lu
Journal:  Neuropsychopharmacology       Date:  2012-07-25       Impact factor: 7.853

Review 4.  PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer.

Authors:  Parvin F Peddi; Sara A Hurvitz
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

5.  Stand up to cancer phase Ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.

Authors:  Ingrid A Mayer; Vandana G Abramson; Steven J Isakoff; Andres Forero; Justin M Balko; María Gabriela Kuba; Melinda E Sanders; Jeffrey T Yap; Annick D Van den Abbeele; Yisheng Li; Lewis C Cantley; Eric Winer; Carlos L Arteaga
Journal:  J Clin Oncol       Date:  2014-03-24       Impact factor: 44.544

6.  Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.

Authors:  Maren Bredemeier; Sabine Kasimir-Bauer; Hans-Christian Kolberg; Thomas Herold; Sarah Synoracki; Siegfried Hauch; Philippos Edimiris; Agnes Bankfalvi; Mitra Tewes; Rainer Kimmig; Bahriye Aktas
Journal:  Mol Med Rep       Date:  2017-03-30       Impact factor: 2.952

7.  Absence of Claudin 11 in CNS Myelin Perturbs Behavior and Neurotransmitter Levels in Mice.

Authors:  Kathleen J Maheras; Marcello Peppi; Farhad Ghoddoussi; Matthew P Galloway; Shane A Perrine; Alexander Gow
Journal:  Sci Rep       Date:  2018-02-28       Impact factor: 4.379

8.  The Impact of the PI3K/Akt Signaling Pathway in Anxiety and Working Memory in Young and Middle-Aged PDK1 K465E Knock-In Mice.

Authors:  Lydia Giménez-Llort; Mikel Santana-Santana; José Ramón Bayascas
Journal:  Front Behav Neurosci       Date:  2020-05-08       Impact factor: 3.558

9.  Metformin attenuates hepatic insulin resistance in type-2 diabetic rats through PI3K/Akt/GLUT-4 signalling independent to bicuculline-sensitive GABAA receptor stimulation.

Authors:  Debapriya Garabadu; Sairam Krishnamurthy
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

10.  Involvement of Epigenetic Modifications of GABAergic Interneurons in Basolateral Amygdala in Anxiety-like Phenotype of Prenatally Stressed Mice.

Authors:  Chunting Zhu; Min Liang; Yingchun Li; Xuejiao Feng; Juan Hong; Rong Zhou
Journal:  Int J Neuropsychopharmacol       Date:  2018-06-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.